See more : Novogene Co., Ltd. (688315.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Cameco Corporation (CCJ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cameco Corporation, a leading company in the Uranium industry within the Energy sector.
- Sharda Cropchem Limited (SHARDACROP.BO) Income Statement Analysis – Financial Results
- Solarvest BioEnergy Inc. (SVS.V) Income Statement Analysis – Financial Results
- AMG Advanced Metallurgical Group N.V. (AMVMF) Income Statement Analysis – Financial Results
- Workday, Inc. (0M18.L) Income Statement Analysis – Financial Results
- Pebblebrook Hotel Trust (PEB-PE) Income Statement Analysis – Financial Results
Cameco Corporation (CCJ)
About Cameco Corporation
Cameco Corporation produces and sells uranium. It operates through two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles or reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.59B | 1.87B | 1.47B | 1.80B | 1.86B | 2.09B | 2.16B | 2.43B | 2.75B | 2.40B | 2.44B | 2.32B | 2.38B | 2.12B | 2.31B | 2.86B | 2.31B | 1.83B | 1.31B | 1.05B | 826.95M | 748.33M | 700.84M | 688.94M | 741.60M | 718.90M | 642.90M | 590.90M | 395.30M | 347.70M | 305.80M |
Cost of Revenue | 1.81B | 1.63B | 1.47B | 1.69B | 1.62B | 1.80B | 1.72B | 1.97B | 2.06B | 1.76B | 1.83B | 1.60B | 1.61B | 1.13B | 1.32B | 1.52B | 1.21B | 1.13B | 814.03M | 623.12M | 538.82M | 486.16M | 422.07M | 413.88M | 428.90M | 400.60M | 316.10M | 298.20M | 190.20M | 175.00M | 146.70M |
Gross Profit | 781.99M | 233.29M | 1.93M | 106.45M | 241.63M | 295.75M | 436.27M | 463.48M | 697.05M | 637.78M | 606.73M | 723.26M | 776.12M | 995.78M | 990.71M | 1.34B | 1.10B | 703.92M | 498.62M | 425.36M | 288.12M | 262.18M | 278.77M | 275.06M | 312.70M | 318.30M | 326.80M | 292.70M | 205.10M | 172.70M | 159.10M |
Gross Profit Ratio | 30.22% | 12.49% | 0.13% | 5.91% | 12.97% | 14.14% | 20.23% | 19.06% | 25.31% | 26.60% | 24.88% | 31.16% | 32.55% | 46.89% | 42.80% | 46.92% | 47.54% | 38.43% | 37.99% | 40.57% | 34.84% | 35.03% | 39.78% | 39.93% | 42.17% | 44.28% | 50.83% | 49.53% | 51.88% | 49.67% | 52.03% |
Research & Development | 21.04M | 12.18M | 7.17M | 3.97M | 6.06M | 1.76M | 5.66M | 4.95M | 6.59M | 5.04M | 7.30M | 9.30M | 100.44M | 4.79M | 630.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 245.54M | 172.03M | 127.57M | 145.34M | 124.87M | 141.55M | 163.10M | 206.65M | 186.81M | 176.39M | 184.98M | 181.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 245.54M | 172.03M | 127.57M | 145.34M | 124.87M | 141.55M | 163.10M | 206.65M | 186.81M | 176.39M | 184.98M | 181.25M | 161.84M | 155.81M | 135.56M | 120.79M | 130.84M | 166.25M | 110.43M | 71.48M | 48.73M | 43.95M | 38.74M | 40.68M | 38.00M | 42.20M | 29.10M | 26.60M | 21.20M | 18.70M | 14.10M |
Other Expenses | 232.55M | 33.52M | -21.60M | -2.55M | 16.42M | 2.16M | -1.32M | 59.57M | -4.60M | 50.59M | -3.37M | -24.75M | 161.84M | 412.21M | 396.55M | 800.03M | 510.07M | 368.54M | 365.42M | 287.68M | 195.14M | 178.24M | 186.33M | 178.49M | 197.50M | 199.50M | 183.80M | 150.80M | 105.70M | 88.10M | 81.90M |
Operating Expenses | 499.13M | 217.73M | 113.13M | 146.76M | 147.35M | 223.21M | 198.73M | 220.11M | 233.66M | 227.99M | 265.11M | 287.72M | 262.28M | 450.82M | 397.18M | 800.03M | 510.07M | 368.54M | 365.42M | 287.68M | 195.14M | 178.24M | 186.33M | 178.49M | 197.50M | 199.50M | 183.80M | 150.80M | 105.70M | 88.10M | 81.90M |
Cost & Expenses | 2.30B | 1.85B | 1.59B | 1.84B | 1.77B | 2.02B | 1.92B | 2.19B | 2.29B | 1.99B | 2.10B | 1.89B | 1.87B | 1.58B | 1.72B | 2.32B | 1.72B | 1.50B | 1.18B | 910.80M | 733.96M | 664.39M | 608.40M | 592.37M | 626.40M | 600.10M | 499.90M | 449.00M | 295.90M | 263.10M | 228.60M |
Interest Income | 87.85M | 37.50M | 6.80M | 10.84M | 29.76M | 22.07M | 5.27M | 4.38M | 5.42M | 7.40M | 6.97M | 20.75M | 24.55M | 47.72M | 6.61M | 16.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 92.05M | 69.04M | 60.71M | 57.74M | 83.93M | 96.72M | 95.23M | 95.05M | 96.51M | 93.19M | 83.21M | 72.36M | 22.00K | 49.88M | 40.74M | 53.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 220.32M | 229.00M | 203.36M | 246.95M | 299.12M | 411.10M | 352.25M | 392.33M | 312.52M | 338.98M | 282.76M | 293.43M | 274.84M | 251.55M | 240.64M | 293.31M | 225.54M | 199.66M | 197.52M | 180.23M | 124.49M | 112.76M | 129.39M | 117.01M | 136.90M | 126.70M | 122.70M | 95.00M | 67.50M | 57.50M | 58.00M |
EBITDA | 799.52M | 307.74M | 147.27M | 201.92M | 430.45M | 464.62M | 218.34M | 312.50M | 754.48M | 313.07M | 615.96M | 479.72M | 808.43M | 833.95M | 1.05B | 1.20B | 813.55M | 535.04M | 411.74M | 315.64M | 217.47M | 196.70M | 221.83M | 213.57M | 252.10M | 245.50M | 265.70M | 236.90M | 166.90M | 142.10M | 135.20M |
EBITDA Ratio | 30.90% | 16.47% | 9.36% | 11.22% | 23.11% | 21.13% | 25.80% | 27.23% | 27.91% | 32.16% | 29.54% | 30.64% | 30.73% | 38.98% | 34.72% | 41.85% | 45.68% | 24.75% | 27.00% | 17.40% | 26.68% | 26.05% | 31.45% | 52.20% | 40.40% | 35.16% | 39.48% | 39.75% | 40.30% | 40.72% | 43.85% |
Operating Income | 282.86M | 130.36M | -52.32M | -6.75M | 154.70M | 70.24M | -127.73M | -141.79M | 245.58M | 38.33M | 264.69M | 269.21M | 506.24M | 542.80M | 2.13B | 524.17M | 475.01M | 335.38M | 39.66M | 260.63M | 92.98M | 83.94M | 92.44M | -51.39M | 69.70M | 102.80M | 143.00M | 141.90M | 99.40M | 84.60M | 77.20M |
Operating Income Ratio | 10.93% | 6.98% | -3.55% | -0.37% | 8.30% | 3.36% | -5.92% | -5.83% | 8.92% | 1.60% | 10.85% | 11.60% | 21.23% | 25.56% | 91.92% | 18.33% | 20.57% | 18.31% | 3.02% | 24.86% | 11.24% | 11.22% | 13.19% | -7.46% | 9.40% | 14.30% | 22.24% | 24.01% | 25.15% | 24.33% | 25.25% |
Total Other Income/Expenses | 204.29M | -45.57M | 32.36M | 39.20M | 42.61M | -30.31M | -79.50M | -12.45M | -324.84M | -157.43M | -149.56M | -68.09M | -44.64M | -11.15M | -36.91M | -182.62M | -9.08M | 10.05M | 151.79M | 118.89M | 91.70M | 9.95M | 15.12M | 7.55M | 7.60M | -9.90M | 4.10M | 900.37K | 6.20M | -400.00K | -1.40M |
Income Before Tax | 487.15M | 84.80M | -103.86M | -39.53M | 135.02M | 39.93M | -207.24M | -154.23M | -79.27M | -119.10M | 227.93M | 218.21M | 450.39M | 531.65M | 766.86M | 484.90M | 465.93M | 345.43M | 274.63M | 379.52M | 196.60M | 104.33M | 107.56M | -43.84M | 77.30M | 92.90M | 147.10M | 142.80M | 105.60M | 84.20M | 75.80M |
Income Before Tax Ratio | 18.83% | 4.54% | -7.04% | -2.20% | 7.25% | 1.91% | -9.61% | -6.34% | -2.88% | -4.97% | 9.35% | 9.40% | 18.89% | 25.03% | 33.13% | 16.96% | 20.17% | 18.86% | 20.92% | 36.20% | 23.77% | 13.94% | 15.35% | -6.36% | 10.42% | 12.92% | 22.88% | 24.17% | 26.71% | 24.22% | 24.79% |
Income Tax Expense | 126.34M | -4.47M | -1.20M | 13.67M | 61.08M | -126.31M | -2.52M | -94.36M | -142.63M | -175.27M | -89.76M | -46.38M | -24.00K | 27.25M | 52.90M | -24.75M | 29.47M | -68.84M | 30.26M | 73.29M | -15.99M | 48.87M | 42.34M | 34.50M | -2.70M | 47.30M | 65.10M | 5.30M | 3.50M | 3.10M | 2.80M |
Net Income | 360.85M | 89.38M | -102.65M | -53.20M | 74.00M | 166.32M | -204.94M | -61.61M | 65.29M | 185.23M | 318.50M | 266.14M | 450.40M | 514.75M | 1.10B | 450.12M | 416.11M | 375.72M | 217.63M | 278.78M | 216.01M | 55.46M | 65.22M | -78.34M | 80.00M | 45.60M | 82.00M | 137.50M | 102.10M | 81.10M | 73.00M |
Net Income Ratio | 13.94% | 4.78% | -6.96% | -2.96% | 3.97% | 7.95% | -9.50% | -2.53% | 2.37% | 7.73% | 13.06% | 11.46% | 18.89% | 24.24% | 47.49% | 15.74% | 18.02% | 20.51% | 16.58% | 26.59% | 26.12% | 7.41% | 9.31% | -11.37% | 10.79% | 6.34% | 12.75% | 23.27% | 25.83% | 23.32% | 23.87% |
EPS | 0.83 | 0.22 | -0.26 | -0.13 | 0.19 | 0.42 | -0.52 | -0.16 | 0.16 | 0.47 | 0.81 | 0.64 | 1.14 | 1.31 | 2.83 | 1.29 | 1.18 | 1.07 | 0.62 | 0.81 | 1.24 | 0.13 | 0.17 | -0.26 | -0.14 | -0.08 | 0.25 | 0.43 | 0.32 | 0.26 | 0.23 |
EPS Diluted | 0.83 | 0.22 | -0.26 | -0.13 | 0.19 | 0.42 | -0.52 | -0.16 | 0.16 | 0.47 | 0.81 | 0.64 | 1.14 | 1.30 | 2.82 | 1.28 | 1.13 | 1.02 | 0.60 | 0.78 | 1.22 | 0.13 | 0.17 | -0.26 | -0.14 | -0.08 | 0.25 | 0.43 | 0.32 | 0.26 | 0.23 |
Weighted Avg Shares Out | 433.38M | 405.49M | 397.63M | 395.83M | 395.80M | 395.79M | 394.12M | 385.07M | 395.79M | 395.74M | 395.43M | 395.23M | 394.66M | 393.17M | 387.96M | 350.13M | 352.64M | 351.14M | 347.53M | 341.37M | 336.38M | 291.51M | 332.06M | 299.38M | 388.21M | 343.91M | 326.15M | 317.63M | 314.47M | 312.24M | 313.17M |
Weighted Avg Shares Out (Dil) | 435.36M | 407.14M | 397.63M | 395.83M | 396.06M | 396.05M | 395.79M | 395.79M | 395.79M | 396.06M | 395.55M | 395.84M | 395.48M | 395.02M | 389.93M | 352.11M | 368.24M | 368.35M | 359.12M | 354.49M | 340.92M | 291.51M | 332.06M | 299.38M | 388.21M | 343.91M | 326.15M | 317.63M | 314.47M | 312.24M | 313.17M |
Artificial Intelligence (AI) Companies Are Going Nuclear: Here Are 3 Energy Stocks You Should Know
Cameco Corporation (CCJ) is Attracting Investor Attention: Here is What You Should Know
Here's Why This Nuclear Energy Stock Soared in November
'Mission Critical' Cameco Goes Nuclear
Where Will Cameco Corporation Be in 5 Years?
Purepoint Uranium and Cameco Approve 2025 Drill Program for Smart Lake Joint Venture
Is Cameco Stock a Buy?
Think It's Too Late to Buy Cameco? Here's the Biggest Reason Why There's Still Time.
Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp
Cameco Corporation (CCJ) Is a Trending Stock: Facts to Know Before Betting on It
Source: https://incomestatements.info
Category: Stock Reports